Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > MMJ Sector

<< Previous

Bullboard Posts

Next >>

Comment by theNormon Jan 11, 2022 11:47am

123 Views

Post# 34303861

RE:RE:RE:RE:RE:RE:RE:MMJ Sector

Turns out Bangada Canaccord has changed their mind, you probably work for them. -On delay Stockwatch @ 51k traded on TSX to make you think there is no vol WHILE there is 280k being bought by Canaccord and Anon on the ATS or Dark Pools from frightened retail. You don't build a TSX company with an agenda you described, there are lots of sauvy investors who've moved Qixleef along with the FDA.

House Positions for C:TBP from 20220111 to 20220111

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
1 Anonymous	205,136	24,629	0.12	160,003	19,250	0.12	45,133	-5,379
33 Canaccord	25,000	3,000	0.12	1,500	187	0.125	23,500	-2,813
7 TD Sec	45,661	5,623	0.123	30,245	3,759	0.124	15,416	-1,864